Portfolio Update
INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 January 2011
|
Total net assets |
£100.8m |
|
NAV per share |
169.2p |
|
Share price |
148.5p |
|
Total value of unquoted investments |
£23.7m |
|
Total number of portfolio companies |
58 |
|
Cash |
0% NAV |
|
Cash committed and reserved to unquoted investments |
9% NAV |
|
Portfolio companies with < 1 year of cash |
12.9% NAV |
Top Ten Holdings
|
Company Name |
% NAV |
|
Shire Ltd |
5.58 |
|
Amgen |
5.31 |
|
Gilead Sciences |
4.87 |
|
Teva |
4.60 |
|
Celgene |
4.48 |
|
Micromet |
4.15 |
|
Insulet |
4.08 |
|
Cadent |
3.90 |
|
Biomarin |
2.90 |
|
Averion |
2.80 |
|
|
----------- |
|
Total |
42.67 |
|
Geographical Allocation |
% |
|
United States |
72 |
|
Europe |
26 |
|
Australia |
2 |
|
Cash |
0 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
76 |
|
Unquoted |
24 |
|
Cash |
0 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
17 FEBRUARY 2011
This information is provided by RNS